LT2016100A - Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą - Google Patents
Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumąInfo
- Publication number
- LT2016100A LT2016100A LT2016100A LT2016100A LT2016100A LT 2016100 A LT2016100 A LT 2016100A LT 2016100 A LT2016100 A LT 2016100A LT 2016100 A LT2016100 A LT 2016100A LT 2016100 A LT2016100 A LT 2016100A
- Authority
- LT
- Lithuania
- Prior art keywords
- vaginolysin
- neutralizing
- antibody fragment
- dimeric antibody
- cytolytic activity
- Prior art date
Links
- 102000008394 Immunoglobulin Fragments Human genes 0.000 title abstract 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 title abstract 2
- 230000001461 cytolytic effect Effects 0.000 title abstract 2
- 230000003472 neutralizing effect Effects 0.000 title 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 abstract 1
- 241000207201 Gardnerella vaginalis Species 0.000 abstract 1
- 208000037009 Vaginitis bacterial Diseases 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Genetiniais metodais sukonstruoti ir išgryninti nauji dimeriniai antikūno fragmentai prieš vaginoliziną, kurie efektyviai neutralizuoja citolizinį vaginolizino poveikį žmogaus ląstelėms ir gali būti naudojami Gardnerella vaginalis sukeltos bakterinės vaginozės profilaktikai ir (arba) gydymui.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LT2016100A LT6389B (lt) | 2016-10-03 | 2016-10-03 | Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LT2016100A LT6389B (lt) | 2016-10-03 | 2016-10-03 | Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LT2016100A true LT2016100A (lt) | 2017-04-10 |
| LT6389B LT6389B (lt) | 2017-05-10 |
Family
ID=58463981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LT2016100A LT6389B (lt) | 2016-10-03 | 2016-10-03 | Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą |
Country Status (1)
| Country | Link |
|---|---|
| LT (1) | LT6389B (lt) |
-
2016
- 2016-10-03 LT LT2016100A patent/LT6389B/lt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| LT6389B (lt) | 2017-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122344T1 (el) | Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων | |
| ZA201903327B (en) | Compositions and methods for the induction of cd8+ t¿cells | |
| MX376691B (es) | Composición farmaceutica que comprende un antagonista de il-4r para tratar una infección cutánea. | |
| MX2021006581A (es) | Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia. | |
| MX381283B (es) | Tratamiento de pénfigo. | |
| MX2022010623A (es) | Terapias de combinacion que comprenden un receptor quimerico de antigeno cd19 para el cancer. | |
| MX2021007003A (es) | Método para tratar el cáncer. | |
| MX2020009780A (es) | Compuestos de inhibidor de autotaxina. | |
| GB2541571A (en) | Pharmaceutical compositions | |
| MX389560B (es) | Enfoque de inmunoterapias de combinación para el tratamiento del cancer. | |
| NZ631701A (en) | Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases | |
| EA201691845A1 (ru) | Фармацевтические композиции терапевтически активных соединений | |
| EA201691844A1 (ru) | Фармацевтические композиции терапевтически активных соединений | |
| MX2018002067A (es) | Manejo con tetraciclina de dermatosis asociada con inhibidor de egfr. | |
| PH12020551573A1 (en) | Pharmaceutical compositions for inhibiting inflammatory cytokines | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| ZA201703467B (en) | Methods of treating ocular conditions | |
| MX2015008486A (es) | Composiciones y metodos para tratar infecciones bacterianas. | |
| AU2016323967A8 (en) | Compositions and methods for the treatment and prevention of radiation dermatitis | |
| LT2016100A (lt) | Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
| TN2015000409A1 (en) | Rifaximin for use in the treating of vaginal infections | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| HK40046229A (en) | Methods and compositions for treating skin disease with recombinant microorganisms | |
| HK40034261A (en) | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Patent application published |
Effective date: 20170410 |
|
| FG9A | Patent granted |
Effective date: 20170510 |
|
| MM9A | Lapsed patents |
Effective date: 20191003 |